1620136-62-0 Usage
Uses
Used in Pharmaceutical Industry:
(S)-6-(2-(2-(trifluoromethyl)pyrrolidin-1-yl)pyrimidin-5-yl)pyridine-2-amine is used as a potential candidate for drug development due to its complex structure and potential biological activity. (S)-6-(2-(2-(trifluoromethyl)pyrrolidin-1-yl)pyrimidin-5-yl)pyridine-2-amine's unique molecular architecture may allow it to interact with specific biological targets, making it a promising candidate for the creation of new medications.
Used in Agrochemical Industry:
In the agrochemical industry, (S)-6-(2-(2-(trifluoromethyl)pyrrolidin-1-yl)pyrimidin-5-yl)pyridine-2-amine may be utilized as a starting point for the development of new pesticides or herbicides. Its complex structure could potentially provide novel modes of action, offering advantages over existing products in terms of efficacy, selectivity, or reduced environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 1620136-62-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,2,0,1,3 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1620136-62:
(9*1)+(8*6)+(7*2)+(6*0)+(5*1)+(4*3)+(3*6)+(2*6)+(1*2)=120
120 % 10 = 0
So 1620136-62-0 is a valid CAS Registry Number.
1620136-62-0Relevant academic research and scientific papers
INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL
-
Page/Page column 126; 127, (2016/04/09)
The present invention relates to pharmaceutical compounds of the Formula (I), or a pharmaceutically acceptable salt or composition thereof, and methods of their use for the treatment of pain, respiratory conditions, as well as inhibiting the Transient Receptor Potential Al ion channel (TRPA1).
INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL
-
Paragraph 0077; 0078, (2014/08/06)
This disclosure describes novel compounds and pharmaceutical compositions for inhibiting the TRPA1 ion channel and/or medical conditions related to TRPA1, such as pain and respiratory conditions.
